Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-19-000033

Sr. VP & General Counsel acquired 3,295 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gardiner Nathaniel S. · Sr. VP & General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-06-26 Exercise or conversion : show line 1 in the form +3,295 $31.42 $103,529 14,871 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-06-26 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −3,295 $31.42 2025-11-20 3,295 21,410 D
Loading xslF345X03/edgar.xml…